Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
64-X Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The profile identifies 1 distinct examiner and 1 distinct art unit. GROSS, CHRISTOPHER M is the busiest examiner, with 1 pending matter. The figures describe one concentrated examination path for the company’s biotechnology and pharmaceutical subject matter.
Counsel should organize the response around the examiner’s stated grounds and the application’s support for the claimed biological or pharmaceutical features. Amendments should be narrowly tied to the disclosure and should preserve useful claim scope where possible. The single examiner and art-unit assignment allow the prosecution team to maintain one consistent position on claim meaning, technical distinctions, and follow-up examination.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GROSS, CHRISTOPHER M | 1 | 63.5% | +40.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023909 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | GROSS, CHRISTOPHER M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023909 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | GROSS, CHRISTOPHER M | — |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18023909 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | GROSS, CHRISTOPHER M | 1684 | §102§112Other | Final Rejection | — | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial64-X Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Christopher M Gross has the most, with 1 of 64-X Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
